Description
The skeptic raised concerns about chronic TFEB activation potentially causing lysosomal storage disorders and cellular dysfunction, but no data was provided to resolve this safety question. This is critical for therapeutic development timelines and dosing strategies.
Source: Debate session sess_SDA-2026-04-10-gba-pd (Analysis: gba-pd)
Resolution criteria
Gap closes when: (1) A 12-week chronic TFEB overactivation study in wild-type mice (via AAV-TFEB or doxycycline-inducible transgene) measures lysosomal biogenesis markers, mTOR activity, and neuronal viability by monthly timepoints; and (2) the study reports no lysosomal storage accumulation (assessed by LysoTracker and EM ultrastructure) and no significant neuronal loss (<= 10% reduction in NeuN+ cells) at the effective dose; and (3) transcriptomic profiling (RNA-seq) at endpoint shows sustained autophagy upregulation without dysregulation of apoptotic pathways (< 2-fold change in caspase-3/9 at FDR < 0.05). Deliverable: chronic safety dataset with histology, EM, and transcriptomics for the therapeutic dose range.
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:18.590010+00:00”, “resolution_summary”: “Resolved by hypothesis h-54c6dd37ce: TFEB/TFE3 Parallel Activation Drives Coordinated Organelle Clearance via CLEAR Network. Supporting evidence includes debate sess_SDA-2026-04-11-gap-debate-20260410-100423-78eecb9f.”, “match_counts”: {“hypothesis_matches”: 2, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-54c6dd37ce”, “title”: “TFEB/TFE3 Parallel Activation Drives Coordinated Organelle Clearance via CLEAR Network”, “score”: 0.235, “reason”: “18 token overlaps; entity overlap: tfeb”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062132-e71b3ef7”, “target_gene”: “TFEB (TFEB), TFE3 (TFE3), mTORC1 (MTOR)”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.727, “confidence_score”: 0.7, “status”: “proposed”, “pubmed_evidence_ids”: [“26942069”, “29045917”, “29311652”, “31501761”, “31801954”]}, {“id”: “h-810ec0eb”, “title”: “TFEB Nuclear Translocation to Reset Lysosomal-Hypoxia Axis”, “score”: 0.225, “reason”: “20 token overlaps; entity overlap: tfeb”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-170057-1bea7d88”, “target_gene”: “TFEB, MTOR”, “target_pathway”: “CLEAR network; mTORC1 signaling; calcineurin-mediated dephosphorylation; VCP-dependent autophagy”, “disease”: “neurodegeneration”, “composite_score”: 0.779, “confidence_score”: 0.52, “status”: “promoted”, “pubmed_evidence_ids”: [“19460733”, “20104022”, “21674719”, “23238394”, “25728669”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-11-gap-debate-20260410-100423-78eecb9f”, “title”: “The debate identified this as a critical mechanistic gap - TFEB may increase lysosomal volume without addressing the fundamental GBA enzyme defect. This distinction is essential for determining therapeutic efficacy and predicting which GBA mutations would respond.\n\nSource: Debate session sess_SDA-2026-04-10-gba-pd (Analysis: gba-pd)”, “score”: 0.451, “reason”: “10 token overlaps; entity overlap: tfeb”, “analysis_id”: “SDA-2026-04-11-gap-debate-20260410-100423-78eecb9f”, “quality_score”: 0.3, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-03-gap-debate-20260403-222617-8eb5bdbc”, “title”: “The debate highlighted TFEB’s role in mitochondrial-lysosomal coupling but couldn’t resolve causation vs correlation. This distinction is critical for determining whether TFEB should be therapeutically enhanced or whether upstream targets are needed.\n\nSource: Debate session sess_SDA-2026-04-02-gap-v2-5d0e3052 (Analysis: SDA-2026-04-02-gap-v2-5d0e3052)”, “score”: 0.348, “reason”: “7 token overlaps; entity overlap: tfeb”, “analysis_id”: “SDA-2026-04-03-gap-debate-20260403-222617-8eb5bdbc”, “quality_score”: 0.95, “status”: “completed”, “target_artifact_id”: “SDA-2026-04-03-gap-debate-20260403-222617-8eb5bdbc”, “target_artifact_type”: “analysis”}, {“id”: “sess_SDA-2026-04-11-gap-debate-20260410-112348-d9e9b948”, “title”: “The debate proposed temporal TFEB modulation but identified no validated biomarkers to guide when TFEB should be enhanced versus inhibited. This represents a critical gap preventing clinical implementation of stage-specific TFEB therapies.\n\nSource: Debate session sess_SDA-2026-04-03-gap-debate-20260403-222617-8eb5bdbc (Analysis: SDA-2026-04-03-gap-debate-20260403-222617-8eb5bdbc)”, “score”: 0.319, “reason”: “6 token overlaps; entity overlap: tfeb”, “analysis_id”: “SDA-2026-04-11-gap-debate-20260410-112348-d9e9b948”, “quality_score”: 1.0, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062150-a6cc7467_task_9aae8fc5”, “title”: “The study shows trehalose causes lysosomal membrane permeabilization (LMP) that paradoxically enhances autophagy rather than causing cytotoxicity. The molecular mechanisms preventing LMP-induced apoptosis while promoting beneficial autophagy remain unclear, which is critical for therapeutic safety.\n\nGap type: unexplained_observation\nSource paper: Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration. (2019, Autophagy, PMID:30335591)”, “score”: 0.317, “reason”: “7 token overlaps; entity overlap: tfeb”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062150-a6cc7467”, “quality_score”: 0.606, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-10-gap-debate-20260410-112348-a10cb6b4”, “title”: “The core causation versus correlation debate remains unresolved despite being central to therapeutic strategy. The distinction determines whether TFEB enhancement or upstream pathway targeting is the optimal approach.\n\nSource: Debate session sess_SDA-2026-04-03-gap-debate-20260403-222617-8eb5bdbc (Analysis: SDA-2026-04-03-gap-debate-20260403-222617-8eb5bdbc)”, “score”: 0.289, “reason”: “5 token overlaps; entity overlap: tfeb”, “analysis_id”: “SDA-2026-04-10-gap-debate-20260410-112348-a10cb6b4”, “quality_score”: 0.5, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}